The radiosensitization effects of Endostar on human lung squamous cancer cells H-520

Cancer Cell International

Volumn 10, Issue , 2010, Pages

  You, Zhen Y ^a   Zhao, Yong ^b   Liu, Feng ^a   Zhang, Ying D ^a   Wang, Jun J ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; ENDOSTAR; ENDOSTATIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG SQUAMOUS CELL CARCINOMA; RADIOSENSITIZATION;

EID: 77952535988     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-10-17     Document Type: Article

References (50)

1. Govindan R, Bogart J, Vokes EE. Locally advanced non - small cell lung cancer: the past, present, and future. J Thorac Oncol 2008, 3:917-28. 10.1097/JTO.0b013e318180270b, 18670313.
2. Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, Faivre FC. Management of unresectable stage III non - small - cell lung cancer with combined - modality therapy: a review of the current literature and recommendations for treatment. Clin lung cancer 2008, 9:92-101. 10.3816/CLC.2008.n.014, 18501095.
3. Bunn PA, Thatcher N. Systemic treatment for advanced (stage IIIb/IV) non - small cell lung cancer: more treatment options; more things to consider. Introduction. Oncologist 2008, 13(Suppl 1):1-4. 10.1634/theoncologist.13-S1-1, 18263768.
4. Marom EM, Martinez CH, Truong MT, Lei X, Sabloff BS, Munden RF, Gladish GW, Herbst RS, Morice RC, Stewart DJ, Jimenez CA, Blumenschein GR, Onn A. Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer. J Thorac Oncol 2008, 3:351-7. 10.1097/JTO.0b013e318168c7e9, 18379352.
5. Folkman J. Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action. Exp Cell Res 2006, 312:594-607. 10.1016/j.yexcr.2005.11.015, 16376330.
6. Moniz M, Yeatermeyer J, Wu TC. Control of cancers by combining antiangiogenesis and cancer immunotherapy. Drug Today 2005, 41:471-94.
7. Huber PE, Bischof M, Jenne J, Heiland S, Peschke P, Saffrich R, Grone HJ, Debus J, Lipson KE, Abdollahi A. Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. Cancer Res 2005, 65:3643-55. 10.1158/0008-5472.CAN-04-1668, 15867359.
8. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-85. 10.1016/S0092-8674(00)81848-6, 9008168.
9. Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela- Arispe ML, Simons M, Sukhatme VP. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res 1999, 59:189-97.
10. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, Sukhatme VP. Endostatin induces endothelial cell apoptosis. J Biol Chem 1999, 274:11721-6. 10.1074/jbc.274.17.11721, 10206987.
11. Dkhissi F, Lu H, Soria C, Opolon P, Griscelli F, Liu H, Khattar P, Mishal Z, Perricaudet M, Li H. Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells. Hum Gene Ther 2003, 14:997-1008. 10.1089/104303403766682250, 12869217.
12. Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engstrom A, Timpl R, Welsh M, Claesson-Welsh L. Endostatin - induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 2000, 95:3403-11.
13. Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co - localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion. J Cell Biochem 2003, 89:133-43. 10.1002/jcb.10489, 12682914.
14. Shi H, Huang Y, Zhou H, Song X, Yuan S, Fu Y, Luo Y. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 2007, 110:2899-906. 10.1182/blood-2007-01-064428, 17615292.
15. Rehn M, Veikkola T, Kukk-Valdre E, Nakamura H, Ilmonen M, Lombardo C, Pihlajaniemi T, Alitalo K, Vuori K. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 2001, 98:1024-9. 10.1073/pnas.031564998, 14702, 11158588.
16. Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z, Keiser N, Kalluri R. Cell surface glypicans are low - affinity endostatin receptors. Mol Cell 2001, 7:811-22. 10.1016/S1097-2765(01)00225-8, 11336704.
17. Wilson RF, Morse MA, Pei P, Renner RJ, Schuller DE, Robertson FM, Mallery SR. Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. Anticancer Res 2003, 23:1289-95.
18. Cui R, Ohashi R, Takahashi F, Yoshioka M, Tominaga S, Sasaki S, Gu T, Takagi Y, Takahashi K. Signal transduction mediated by endostatin directly modulates cellular function of lung cancer cells in vitro. Cancer Sci 2007, 98:830-7. 10.1111/j.1349-7006.2007.00459.x, 17419709.
19. Ling Y, Yang Y, Lu N, You QD, Wang S, Gao Y, Chen Y, Guo QL. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF - induced tyrosine phosphorylation of KDR/Flk - 1 of endothelial cells. Biochem Bioph Res Comm 2007, 361:79-84.
20. Song HF, Liu XW, Zhang HN, Zhu BZ, Yuan SJ, Liu SY, Tang ZM. Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys. Acta Pharmacol Sin 2005, 26:124-8. 10.1111/j.1745-7254.2005.00009.x, 15659125.
21. Madeo F, Herker E, Maldener C, Wissing S, Lachelt S, Herlan M, Fehr M, Lauber K, Sigrist SJ, Wesselborg S, Frohlich KU. A caspase - related protease regulates apoptosis in yeast. Mol Cell 2002, 9:911-7. 10.1016/S1097-2765(02)00501-4, 11983181.
22. Yokoyama Y, Sedgewick G, Ramakrishnan S. Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination. Cancer Res 2007, 67:10813-10822. 10.1158/0008-5472.CAN-07-0172, 18006826.
23. Yokoyama Y, Ramakrishnan S. Binding of endostatin to human ovarian cancer cells inhibits cell attachment. Int J Cancer 2007, 121:2402-9. 10.1002/ijc.22935, 17597104.
24. Lu N, Ling Y, Gao Y, Chen Y, Mu R, Qi Q, Liu W, Zhang H, Gu H, Wang S, Yang Y, Guo Q. Endostar suppresses invasion through downregulating the expression of matrix metalloproteinase - 2/9 in MDA-MB-435 human breast cancer cells. Exp Biol Med 2008, 233:1013-20.
25. Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR. Antitumor interaction of short-course endostatin and ionizing radiation. Cancer J 2000, 6:287-93.
26. Shi W, Teschendorf C, Muzyczka N, Siemann DW. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiother Oncol 2003, 66:1-9. 10.1016/S0167-8140(02)00280-3, 12559515.
27. Fenton BM, Paoni SF, Grimwood BG, Ding I. Disparate effects of endostatin on tumor vascular perfusion and hypoxia in two murine mammary carcinomas. Int J Radiat Oncol Biol Phys 2003, 57:1038-46.
28. Wen QL, Meng MB, Yang B, Tu LL, Jia LL, Zhou X. Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice. Cancer Science 2009, 100:1510-9. 10.1111/j.1349-7006.2009.01193.x, 19459845.
29. Itasaka S, Komaki R, Herbst RS, Shibuya K, Shintani T, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O'Reilly MS. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys 2007, 67:870-8. 1976280, 17293237.
30. Wu DS, Wu CM, Huang TH, Xie QD. Combined effects of radiotherapy and endostatin gene therapy in melanoma tumor model. Radiat Environ Biophys 2008, 47:285-91. 10.1007/s00411-007-0144-x, 18060421.
31. Greenberger JS. Antitumor interaction of short course endostatin and ionizing radiation. Cancer J 2000, 6:279-81.
32. Oehler C, Dickinson DJ, Broggini-Tenzer A, Hofstetter B, Hollenstein A, Riesterer O, Vuong V, Pruschy M. Current concepts for the combined treatment modality of ionizing radiation with anticancer agents. Curr Pharm Design 2007, 13:519-35.
33. Du Z, Hou S. The anti - angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism. J Urol 2003, 170:2000-3. 10.1097/01.ju.0000091879.18156.22, 14532841.
34. Raut CP, Takamori RK, Davis DW, Sweeney GB, O'Reilly MS, McConkey DJ. Direct effects of recombinant human endostatin on tumor cell IL-8 production are associated with increased endothelial cell apoptosis in an orthotopic model of human pancreatic cancer. Cancer Biol Ther 2004, 3:679-87.
35. te Velde EA, Reijerkerk A, Brandsma D, Vogten JM, Wu Y, Kranenburg O, Voest EE, Gebbink M, Borel Rinkes IH. Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells. Br J Cancer 2005, 92:729-35. 10.1038/sj.bjc.6602385, 2361873, 15700042.
36. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004, 59:928-42. 10.1016/j.ijrobp.2004.03.005, 15234026.
37. Xu R, Du P, Fan JJ, Zhang Q, Li TP, Gan RB. High - level expression and secretion of recombinant mouse endostatin by Escherichia coli. Protein Expres Purif 2002, 24:453-9.
38. Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B, Ramchandran R, Pestell R, Sukhatme VP. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem 2002, 277:16464-9. 10.1074/jbc.M112274200, 11815623.
39. Dhanabal M, Volk R, Ramchandran R, Simons M, Sukhatme VP. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophy Res Comm 1999, 258:345-2.
40. Pauwels B, Korst AE, Pattyn GG, Lambrechts HA, Van Bockstaele DR, Vermeulen K, Lenjou M, de Pooter CM, Vermorken JB, Lardon F. Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro. Int J Radiat Oncol Biol Phys 2003, 57:1075-83.
41. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett 2004, 149:19-23. 10.1016/j.toxlet.2003.12.017, 15093244.
42. Ren B, Wang Y, Ndebele K, Zhi Q, Chen FH, Wang YZ, Parangi S. Multiple signaling is involved in endostatin - mediated apoptosis in ECV 304 endothelial cells. Front Biosci 2005, 10:1089-97. 10.2741/1602, 15769608.
43. Davis DW, Shen Y, Mullani NA, Wen S, Herbst RS, O'Reilly M, Abbruzzese JL, McConkey DJ. Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors. Clin Cancer Res 2004, 10:33-42. 10.1158/1078-0432.CCR-0736-3, 14734449.
44. Johnson GE, Ivanov VN, Hei TK. Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis 2008, 13:790-802. 10.1007/s10495-008-0212-y, 18454317.
45. Gupta VK, Jaskowiak NT, Beckett MA, Mauceri HJ, Grunstein J, Johnson RS, Calvin DA, Nodzenski E, Pejovic M, Kufe DW, Posner MC, Weichselbaum RR. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. Cancer J 2002, 8:47-54. 10.1097/00130404-200201000-00009, 11895203.
46. Choi CH, Xu H, Bark H, Lee TB, Yun J, Kang SI, Oh YK. Balance of NF - kappaB and p38 MAPK is a determinant of radiosensitivity of the AML - 2 and its doxorubicin-resistant cell lines. Leukemia Res 2007, 31:1267-76.
47. Anoopkumar-Dukie S, Conere T, Carey JB, Allshire A. Radical mediators and mitogen - activated protein kinase signaling in oxygen - dependent radiosensitivity of human tumor cell lines. Free Radical Bio Med 2005, 39:188-94.
48. Kumar P, Miller AI, Polverini PJ. p38 MAPK mediates gamma - irradiation - induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3 - kinase - Akt - Bcl-2 pathway. J Biol Chem 2004, 279:43352-60. 10.1074/jbc.M405777200, 15292252.
49. Viniegra JG, Martinez N, Modirassari P, Losa JH, Parada CC, Lobo VJ, Lobo VJ, Luquero CI, Alvarez-Vallina L, Ramon CS, Rojas JM, Sanchez-Prieto R. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem 2005, 280:4029-36. 10.1074/jbc.M410344200, 15546863.
50. Campbell M, Collery R, McEvoy A, Gardiner TA, Stitt AW, Brankin B. Involvement of MAPKs in endostatin - mediated regulation of blood - retinal barrier function. Curr Eye Res 2006, 31:1033-45. 10.1080/02713680601013025, 17169842.